Response to Walsh

Peter Ström¹, Anna Wallerstedt Lantz^{1

2}, Henrik Grönberg¹, Tobias Nordström^{1

2

3}, Martin Eklund¹

Affiliations

¹ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
² Department of Urology, Karolinska University Hospital, Solna, Sweden.
³ Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.

Comment

Peter Ström et al. J Natl Cancer Inst. 2019.

. 2019 Jul 1;111(7):748.

doi: 10.1093/jnci/djy187.

Peter Ström¹, Anna Wallerstedt Lantz^{1

2}, Henrik Grönberg¹, Tobias Nordström^{1

2

3}, Martin Eklund¹

¹ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
² Department of Urology, Karolinska University Hospital, Solna, Sweden.
³ Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Comment on

Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.
Wallerstedt A, Strom P, Gronberg H, Nordstrom T, Eklund M. Wallerstedt A, et al. J Natl Cancer Inst. 2018 Nov 1;110(11):1216-1221. doi: 10.1093/jnci/djy036. J Natl Cancer Inst. 2018. PMID: 29548030
RE: Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.
Walsh PC. Walsh PC. J Natl Cancer Inst. 2019 Jul 1;111(7):747. doi: 10.1093/jnci/djy186. J Natl Cancer Inst. 2019. PMID: 30380081 No abstract available.